{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T22:13:55Z","timestamp":1766268835075},"reference-count":18,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,10]]},"abstract":"<jats:title>Abstract:<\/jats:title>\n          <jats:p>Aggressive extracutaneous B-cell lymphomas span the various stages of B-cell ontogeny and include B-cell lymphoblastic lymphoma, Burkitt lymphoma, mantle cell lymphoma, and diffuse large B-cell lymphoma. Diffuse large B-cell lymphomas represent the most common histologic subtype of non-Hodgkin lymphomas, comprising 30% of adult non-Hodgkin lymphomas in the United States. A distinctive form of diffuse large B-cell lymphoma is the double-hit lymphoma, with most cases exhibiting a combined MYC and BCL2 rearrangement, leading some hematopathologists to propose the term MYC\/BCL2 lymphoma. More recently, MYC rearrangement with multiple copies\/gain of BCL2 or multiple copies\/gain of MYC with a BCL2 rearrangement have been described and exhibit a very similar clinical course to conventional double-hit lymphomas. We report the seventh case of diffuse large B-cell lymphoma exhibiting this distinct cytogenetic abnormality and the first reported case in the skin. The patient's clinical course was aggressive, succumbing to disease 18 months after his initial presentation.<\/jats:p>","DOI":"10.1097\/dad.0000000000000607","type":"journal-article","created":{"date-parts":[[2016,7,8]],"date-time":"2016-07-08T16:34:51Z","timestamp":1467995691000},"page":"769-774","source":"Crossref","is-referenced-by-count":2,"title":["Primary Cutaneous Diffuse Large B-Cell Lymphoma With a MYC-IGH Rearrangement and Gain of BCL2: Expanding the Spectrum of MYC\/BCL2 Double-Hit Lymphomas"],"prefix":"10.1097","volume":"38","author":[{"given":"Natalia","family":"Testo","sequence":"first","affiliation":[{"name":"University of North Texas Health Science Center, Texas College of Osteopathic Medicine;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luke C.","family":"Olson","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, New York Presbyterian Hospital-Weill Cornell Medicine, New York, NY; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shivakumar","family":"Subramaniyam","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, New York Presbyterian Hospital-Weill Cornell Medicine, New York, NY; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ty","family":"Hanson","sequence":"additional","affiliation":[{"name":"Aberdeen Dermatology Clinic, School of Health Sciences, University of South Dakota, Aberdeen, SD."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cynthia M.","family":"Magro","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, New York Presbyterian Hospital-Weill Cornell Medicine, New York, NY; and"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230908","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1182\/blood-2004-09-3502","article-title":"WHO-EORTC classification for cutaneous lymphomas","volume":"105","author":"Willemze","year":"2005","journal-title":"Blood"},{"key":"R2-20230908","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/DAD.0b013e31829beaa7","article-title":"Cutaneous double-hit B-cell lymphoma: an aggressive form of B-cell lymphoma with a propensity for cutaneous dissemination","volume":"36","author":"Magro","year":"2014","journal-title":"Am J Dermatopathol."},{"key":"R3-20230908","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1200\/JCO.2000.18.10.2152","article-title":"Primary cutaneous B-cell lymphoma: review and current concepts","volume":"18","author":"Pandolfino","year":"2000","journal-title":"J Clin Oncol."},{"key":"R4-20230908","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1038\/jid.2008.357","article-title":"Fine-mapping chromosomal loss at 9p21: correlation with prognosis in primary cutaneous diffuse large B-cell lymphoma, leg type","volume":"129","author":"Senff","year":"2009","journal-title":"J Invest Dermatol."},{"key":"R5-20230908","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/modpathol.2011.147","article-title":"B-cell lymphomas with MYC\/8q24 rearrangements and IGH@BCL2\/t(14;18)(q32;q21): an aggressive disease with heterogeneous histology, germinal center B-cell immunophenotype and poor outcome","volume":"25","author":"Li","year":"2012","journal-title":"Mod Pathol."},{"key":"R6-20230908","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1097\/00000478-200404000-00005","article-title":"Immunohistochemical expression patterns of germinal center and activation B-cell markers correlate with prognosis in diffuse large B-cell lymphoma","volume":"28","author":"Chang","year":"2004","journal-title":"Am J Surg Pathol."},{"key":"R7-20230908","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1097\/PAS.0b013e3181cd3aeb","article-title":"B-cell lymphomas with concurrent IGH-BCL2 and MYC rearrangements are aggressive neoplasms with clinical and pathologic features distinct from Burkitt lymphoma and diffuse large B-cell lymphoma","volume":"34","author":"Snuderl","year":"2010","journal-title":"Am J Surg Pathol."},{"key":"R8-20230908","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/modpathol.2012.178","article-title":"Aggressive B-cell lymphomas: how many categories do we need?","volume":"26","author":"Said","year":"2013","journal-title":"Mod Pathol."},{"key":"R9-20230908","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1038\/modpathol.2014.95","article-title":"B-cell lymphomas with concurrent MYC and BCL2 abnormalities other than translocations behave similarly to MYC\/BCL2 double-hit lymphomas","volume":"28","author":"Li","year":"2015","journal-title":"Mod Pathol."},{"key":"R10-20230908","first-page":"277","article-title":"+18 or trisomy 18 in lymphoproliferative disorders","volume":"7","author":"Van Dyke","year":"2003","journal-title":"Atlas Genet Cytogenet Oncol Haemetol."},{"key":"R11-20230908","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1097\/01.pas.0000167362.06148.95","article-title":"Diffuse large B-cell lymphoma with extra Bcl-2 gene signals detected by FISH analysis is associated with a \u201cnon-germinal center phenotype\u201d","volume":"29","author":"Kusumoto","year":"2005","journal-title":"Am J Surg Pathol."},{"key":"R12-20230908","doi-asserted-by":"crossref","first-page":"12a","DOI":"10.1182\/blood.V104.11.26.26","article-title":"Mechanisms of bcl-2 protein expression in diffuse large B-cell lymphoma [Abstract]","volume":"104","author":"Farinha","year":"2004","journal-title":"Blood"},{"key":"R13-20230908","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1182\/blood-2003-05-1545","article-title":"Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray","volume":"103","author":"Hans","year":"2004","journal-title":"Blood"},{"key":"R14-20230908","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1182\/blood.V90.3.1168","article-title":"BCL2 overexpression associated with chromosomal amplification in diffuse large B-cell lymphoma","volume":"90","author":"Monni","year":"1997","journal-title":"Blood"},{"key":"R15-20230908","doi-asserted-by":"crossref","first-page":"3498","DOI":"10.1200\/JCO.2004.11.025","article-title":"Clinicopathologic significance and prognostic value of chromosomal imbalances in diffuse large B-cell lymphoma","volume":"22","author":"Bea","year":"2004","journal-title":"J Clin Oncol."},{"key":"R16-20230908","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s00204-014-1448-7","article-title":"The mystery of BCL2 family: bcl-2 proteins and apoptosis: an update","volume":"89","author":"Siddiqui","year":"2015","journal-title":"Arch Toxicol."},{"key":"R17-20230908","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1097\/PAS.0b013e3181e5060a","article-title":"IgM expression on paraffin sections distinguishes primary cutaneous large B-cell lymphoma, leg type from primary cutaneous follicle center lymphoma","volume":"34","author":"Koens","year":"2010","journal-title":"Am J Surg Pathol."},{"key":"R18-20230908","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1111\/j.1365-2133.2003.05649.x","article-title":"Bcl-2, Bcl-6 and CD10 expression in cutaneous B-cell lymphoma: further support for a follicle centre cell origin and differential diagnostic significance","volume":"149","author":"Hoefnagel","year":"2003","journal-title":"Br J Dermatol."}],"container-title":["The American Journal of Dermatopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00000372-201610000-00011","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,8]],"date-time":"2023-09-08T04:00:30Z","timestamp":1694145630000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00000372-201610000-00011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":18,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/dad.0000000000000607","relation":{},"ISSN":["0193-1091"],"issn-type":[{"value":"0193-1091","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]}}}